Medical device maker Invacare lays of nearly 150 from an Ohio manufacturing facility, citing a "decline in production" following an injunction agreement with the FDA.
The decline is the result of manufacturing limits related to an FDA injunction that was approved last week, according to a press release.
The cuts represents about 40% of the Ohio facility's total workforce. The remaining 222 employees will either remain in their current roles or be reassigned to other roles on the Elyria site, the company noted.
"While we regret having to take this step, we recognize the need to align our workforce with our production volume," president & CEO Gerry Blouch said in prepared remarks. "We remain committed to achieving full regulatory compliance and to resuming full operations at Taylor Street as quickly as possible. Over the past year, we have made significant investments of time, people and resources to achieve regulatory compliance and make Invacare's Taylor Street manufacturing facility an even stronger operation."
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...